Cargando…

2064: Deconstructing the peptide specificity of TCR recognition

OBJECTIVES/SPECIFIC AIMS: The off-target and organ-specific toxicities observed in cancer immunotherapy present an obstacle to T-cell-based therapeutics. A recent clinical trial underscored the need for improved methods to define TCR specificity after melanoma patients treated with TCR engineered T-...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, Timothy P., Mendoza, Juan, Garcia, K. C., Baker, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799170/
http://dx.doi.org/10.1017/cts.2017.195